Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Proteros biostructures is a premier contract research organization (CRO) specializing in structure-based drug discovery and structural biology. Co-founded by Nobel Laureate Robert Huber, the company provides high-resolution X-ray crystallography, cryo-electron microscopy (cryo-EM), and biophysical screening services to unlock technically challenging drug targets. Its "High Hanging Fruit" platform integrates protein science, structural biology, and medicinal chemistry to accelerate the discovery of novel small molecule leads. Proteros serves a global client base, including major pharmaceutical companies and biotechnology firms, through its headquarters in Martinsried, Germany, and its US office in Cambridge. The company is particularly recognized for its expertise in fragment-based lead generation and its proprietary technologies for protein-ligand complex analysis.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Proteros Fragments.